In one paragraphArticle in Journal of clinical microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
13 authors.
Supram Hosuru Subramanya *Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, , New York, New York, USA.ORCID 0000-0002-3488-4217 Lee S Gottesdiener *Division of Infectious Diseases, Department of Medicine, Weill Cornell Medicine, , New York, New York, USA.ORCID 0009-0009-6123-498X Jamie MarinoDepartment of Pathology and Laboratory Medicine, Weill Cornell Medicine, , New York, New York, USA.ORCID 0009-0006-5604-7117 Juliet N BarkerDivision of Hematology and Oncology, Department of Medicine, Weill Cornell Medicine, , New York, New York, USA.
Tsiporah ShoreDivision of Hematology and Oncology, Department of Medicine, Weill Cornell Medicine, , New York, New York, USA.
Rosemary SoaveDivision of Infectious Diseases, Department of Medicine, Weill Cornell Medicine, , New York, New York, USA.
Markus PlateDivision of Infectious Diseases, Department of Medicine, Weill Cornell Medicine, , New York, New York, USA.
John R LeeDivision of Nephrology and Hypertension, Department of Medicine, Weill Cornell Medicine, , New York, New York, USA.
Barry N KreiswirthCenter for Discovery and Innovation, Hackensack Meridian Health, Nutley, New Jersey, USA.ORCID 0000-0002-0243-131X Laura B GoodmanDepartment of Public and Ecosystem Health, College of Veterinary Medicine, Cornell University, Ithaca, New York, USA.ORCID 0000-0002-8327-3092 Casey L CazerDepartment of Public and Ecosystem Health, College of Veterinary Medicine, Cornell University, Ithaca, New York, USA.
Lars F WestbladeDepartment of Pathology and Laboratory Medicine, Weill Cornell Medicine, , New York, New York, USA.
Michael J SatlinDepartment of Pathology and Laboratory Medicine, Weill Cornell Medicine, , New York, New York, USA.ORCID 0000-0003-4711-5334 Funding
Institutional Career Development CoreKL2TR002385 · NCATS · WEILL MEDICAL COLL OF CORNELL UNIV · PI YUAN-SHAN ZHU · 2017 to 2026
$13.3MT32: Pathogenesis of Infectious Diseases Training ProgramT32AI007613 · NIAID · WEILL MEDICAL COLL OF CORNELL UNIV · PI ROY M. GULICK · 1999 to 2026
$8.8MScreening for Fluoroquinolone-Resistant Viridans Group Streptococci to Individualize Infection Prevention Strategies in Neutropenic PatientsR21AI182845 · NIAID · WEILL MEDICAL COLL OF CORNELL UNIV · PI SATLIN, MICHAEL JOSEPH · 2024 to 2025
$466kNational Institute of Allergy and Infectious Diseases R21 AI182845National Institute of Allergy and Infectious Diseases T32 AI007613NCATS NIH HHS KL2 TR002385NIAID NIH HHS R21 AI182845NIAID NIH HHS T32 AI007613
6 · The paper itselfAbstract
Patients undergoing hematopoietic cell transplantation (HCT) who receive fluoroquinolone prophylaxis are at high risk for bacteremia due to fluoroquinolone-resistant viridans group streptococci (FQ-R VGS), particularly
Indexed as
Anti-Bacterial AgentsBacteriological TechniquesCarrier StateDrug Resistance, BacterialFluoroquinolonesHematopoietic Stem Cell TransplantationStreptococcal InfectionsViridans StreptococciAdultAgedAntibiotic ProphylaxisBacteremiaFemaleHumansMaleMiddle AgedAnti-Bacterial AgentsFluoroquinolonescolonizationdiagnosticsfluoroquinolone resistanceneutropeniaviridans streptococci
Identifiers
PMID42626955
PMCPMC13556186
What OpenQuestion holds
Textmetadata
Read underepoch 390